Michael S. Cuffe - Feb 16, 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and Chief Clinical Officer
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Feb 16, 2024
Transactions value $: -$1,916,713
Form type: 4
Date filed: 2/21/2024, 07:29 PM
Previous filing: Feb 2, 2024
Next filing: May 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+12.6K	+50.38%	$0.00	37.5K	Feb 16, 2024	Direct	F1
transaction	HCA	Common Stock	Award	$0	+4.42K	+11.79%	$0.00	41.9K	Feb 16, 2024	Direct	F2
transaction	HCA	Common Stock	Tax liability	-$1.92M	-6.21K	-14.82%	$308.55	35.7K	Feb 16, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 3, 2021, the reporting person was granted 6,280 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
F2	On October 25, 2021, the reporting person was granted 2,210 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On February 3, 2021, the reporting person was granted 6,280 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

On October 25, 2021, the reporting person was granted 2,210 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.